U.S. Markets open in 7 hrs 27 mins

Can The Uptrend Continue for Aeterna Zentaris (AEZS)?

Style Box ETF report for EPS

Investors certainly have to be happy with Aeterna Zentaris Inc. AEZS and its short term performance. After all, the stock has jumped by 40.4% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for AEZS?

While we can never know for sure, it is pretty encouraging that estimates for AEZS have moved higher in the past few weeks, meaning that analyst sentiment is moving in the right way. Plus, the stock actually has a Zacks Rank #1 (Strong Buy), so the recent move higher for this spotlighted company may definitely continue over the next few weeks. You can see the complete list of today’s Zacks #1 Rank stocks here.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AEterna Zentaris Inc. (AEZS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research